21st century biodefence: Risks, trade-offs & responsible science

ILPI Publications > Policy Papers

The dramatic increase in the number of laboratories and scientists working on dangerous pathogens and toxins has exacerbated safety and security risks

By Gregory Koblentz and Filippa Lentzos
  • There has been a dramatic increase in biodefence activities and in the number of facilities and researchers working with dangerous pathogens around the world.
  • This has generated a number of trade-offs, risks related to safety, security, responsible science and transparency.
  • The 2016 BWC Review Conference must encourage states to implement stringent national biosafety, biosecurity and dual-use research regulations; task the science advisory group to develop clear, internationally-recognised guidelines governing dual-use research of concern (DURC); establish a working group to revise the CBMs; and encourage states to participate in the CBM mechanism as well as more interactive information exchanges such as peer review and compliance assessment.
BWC Review Conference Series (Paper No. 3 of 3) Published: November 2016

Download article as PDF.

03-21st-century-biodefence-gold-thumbnail